

Material Test Reports (MTRs) and Certificates of Analysis (COAs) are critical documents for ensuring quality, compliance, and traceability across manufacturing, metals, chemicals, pharmaceuticals, and food industries.

In several regulated and precision-driven industries—such as aerospace alloys, medical implants, oil & gas tubing, and automotive safety components—manufacturers must manage both a Material Test Report (MTR) from their suppliers and a Certificate of Analysis (COA) generated within their own plant. Although these two documents serve related purposes, they originate at different stages of the value chain, which often creates a complex and time-consuming workflow. As production volumes and compliance demands rise, this dual-document requirement has become one of the most underestimated bottlenecks in quality assurance.
The MTR provides upstream material assurance. It is issued by the metal mill or supplier and validates the raw material’s chemical composition, mechanical properties, heat number, and conformance to standards such as ASTM or ASME. In simple terms, an MTR answers the question: Was the material manufactured correctly before entering our factory? On the other hand, the COA reflects downstream production validation. It is created by the manufacturer after machining, forming, coating, or heat treatment and includes dimensional checks, surface finish values, additional chemical or mechanical tests, and any customer-specific inspections. A COA answers the complementary question: Did the finished product meet the customer’s exact requirements?
In high-assurance sectors like precision tubing for oil wells, orthopedic components, superalloy blades, and critical automotive parts, customers insist on receiving both documents for each batch. Together, MTRs and COAs provide full lifecycle traceability, from the moment the alloy is melted to the moment the final component is shipped.
Handling both MTRs and COAs manually quickly becomes inefficient, especially when manufacturers process dozens or hundreds of batches per day. Quality teams often find themselves spending significant time cross-verifying values from two different documents that rarely follow the same layout. Supplier MTRs come in varied PDF formats, forcing inspectors to search for chemistry, mechanical properties, heat numbers, and material grades across different designs. Meanwhile, COAs require operators to retype test values into ERP systems, quality modules, or customer-specific templates. Even a minor typing error can lead to compliance issues or customer escalations.
Another common issue is the last-minute document scramble before dispatch. Production may finish on schedule, but shipments get delayed because COAs are still being compiled, matched with the correct MTRs, or double-checked for accuracy. For companies operating on tight delivery windows—especially those supplying aerospace or automotive customers—documentation delays quickly become a major operational risk.
Automation platforms designed for industrial documentation offer a structured way to simplify this dual-document workflow. Modern solutions can read MTRs directly from PDFs, regardless of the supplier’s format, and accurately extract critical values such as chemistry, tensile strength, hardness, and heat numbers. This eliminates the need for templates, manual scanning, or repetitive data entry.
At the same time, COA generation can be streamlined by pulling inspection results directly from measurement equipment or internal databases. As soon as final testing is done, the system automatically populates the COA in the correct customer format, eliminating inconsistencies and making the document available far earlier in the dispatch cycle. The real strength of automation is the ability to match MTR and COA data in real time. Heat numbers, material grades, tolerances, and specification limits are cross-validated instantly, and any deviation is flagged for review. This ensures that non-conforming material is caught before it leaves the facility.
Automation also integrates seamlessly with ERP and quality systems. Once documents are validated, they are linked to the correct work order, stored in the system of record, and, if required, automatically shared with the customer. This end-to-end workflow significantly reduces manual handling and creates a reliable audit trail.
Manufacturers adopting COA and MTR automation report substantial improvements in efficiency and compliance. Manual processing time drops sharply, freeing quality teams to focus on more value-added tasks. Errors linked to data entry or document mismatches reduce dramatically, improving customer trust and reducing the risk of returns or corrective actions. Shipment delays caused by documentation bottlenecks disappear, enabling a smoother and more predictable dispatch cycle. Perhaps most importantly, companies gain stronger traceability and easier audit readiness—two factors that have become critical in regulated industries.
As industries that rely on MTRs and COAs evolve toward tighter specifications and faster delivery expectations, the limitations of manual document handling become more visible. Automating both documents together—not as separate workflows—creates a unified, traceable process that supports quality, compliance, and operational speed. For manufacturers working with high-performance alloys, medical-grade materials, or precision-engineered components, this integrated approach is quickly becoming essential to maintain competitiveness and reliability.

In the pharmaceutical industry, where patient safety and regulatory compliance are paramount, Certificates of Analysis (COAs) are critical. These documents verify that raw materials, intermediates, and finished products meet predefined quality and safety standards. As companies adopt automation to streamline workflows, one truth stands out: in COA automation, the most critical step is ensuring data accuracy and integrity at the point of extraction.
Pharma COAs arrive in a wide variety of formats—PDFs, scanned images, or supplier-specific templates. Each document carries crucial details: assay results, impurity levels, dissolution rates, and compliance thresholds. A single misinterpretation—for example, reading “0.02%” as “0.2%”—can cascade into flawed validations, ERP mis-entries, or incorrect regulatory filings. The consequences can be severe: compliance breaches, costly recalls, or even risks to patient health.
A 2023 Deloitte survey revealed that up to 40% of pharma firms report compliance gaps directly tied to poor data capture in quality documentation. This proves that even the most advanced validation or integration systems cannot correct errors created at the extraction stage.
Global regulators such as the FDA (21 CFR Part 11) and EMA place strict emphasis on data integrity, requiring pharmaceutical firms to prove that their records are authentic, consistent, and accurate. Any missteps in COA accuracy can result in FDA warning letters, production halts, or import bans.
Beyond regulators, clients demand error-free data as well. In tightly interlinked supply chains, a single inaccurate COA entry can delay drug release or shake trust. According to PwC, nearly 60% of pharma executives rank error-free quality data as the top factor in sustaining supplier-client relationships.
Novartis, one of the world’s largest pharmaceutical companies, undertook a digital quality transformation initiative to strengthen its global supply chain. By implementing AI-driven document processing for COAs, Novartis was able to reduce manual quality checks by 65% and cut down review cycle times significantly. More importantly, automated extraction ensured accurate capture of assay and impurity data across thousands of supplier COAs. This allowed faster batch release, improved regulatory audit readiness, and created a single source of truth across their ERP and LIMS platforms.
Their experience illustrates how building accuracy at the point of extraction forms the foundation for efficiency, compliance, and trust. Without that foundation, downstream automation risks collapsing like a skyscraper built on weak ground.
Accurate COA automation delivers multiple benefits. It reduces manual verification time by 50–70%, freeing skilled quality teams for higher-value work. It also minimizes human error, lowering the likelihood of recalls that, according to FDA estimates, cost $20 million to $100 million per incident. McKinsey further notes that pharma quality teams spend 25–30% of their time on manual document checks—time that automation can reclaim.
Ultimately, the integrity of COA data at extraction determines whether automation is a compliance liability or a competitive advantage. For pharmaceutical companies, the future of automation is not just about digitization—it is about building a foundation of trust, accuracy, and reliability from the very first data point.

For manufacturers striving to maintain quality excellence and meet global standards, ISO 9001:2015 remains the benchmark for building trust and consistency in product delivery. At the heart of this compliance journey lies the need for reliable documentation, accurate testing records, and controlled processes. This is where COA (Certificate of Analysis) automation becomes a game-changer—especially when integrated into Quality Management System (QMS) software.
A Certificate of Analysis is a critical document that certifies a product’s compliance with predefined specifications, such as chemical composition, mechanical properties, or microbiological content. In industries like pharmaceuticals, chemicals, metals, and food processing, COAs are not just quality markers—they are regulatory necessities.
Yet, many organizations still rely on manual data entry and fragmented systems to manage these certificates, leading to inconsistencies, delays, and compliance risks.
Let’s explore how COA automation directly supports the key clauses of ISO 9001:2015, transforming your QMS software into a proactive compliance engine.
ISO 9001 calls for data-driven quality decisions. COA automation ensures that test results are accurately captured from labs or supplier systems using OCR and AI tools. The result? Reliable data sets that allow quality teams to take informed decisions with full traceability.
Maintaining version-controlled, accessible, and secure documentation is a requirement. Automated COAs are digitally stored within the QMS, indexed by batch or supplier, and available at a click—removing the chaos of paper trails and misplaced files.
Quality assurance depends on releasing only compliant batches. Automated COAs link directly to product specifications and flag out-of-spec results in real time, preventing faulty shipments and ensuring product integrity.
When customers demand timely and accurate documentation, COA automation delivers. It enables fast generation of tailored COAs per customer specs, enhancing transparency and building trust.
Manual COA workflows introduce errors and slow response times. Automation mitigates these risks by enforcing data validation rules, reducing human error, and offering early warnings for non-conformities.
Automated COAs feed valuable quality trends into your QMS. With the right analytics, businesses can detect recurring issues, improve supplier performance, and optimize manufacturing processes—all aligning with ISO's focus on continuous improvement.
Consider a pharmaceutical manufacturer managing hundreds of raw material lots weekly. With COA automation integrated into their QMS, each incoming batch is automatically verified against specifications. Deviations trigger non-conformance workflows, while compliant batches generate instant COA documents for customer and regulatory records. The result? Faster release cycles, zero data-entry errors, and audit readiness 24/7.
Achieving ISO 9001 compliance is not just about ticking checkboxes. It’s about building systems that ensure product quality, minimize risk, and enhance customer satisfaction. COA automation plays a vital role in this ecosystem by transforming a traditionally manual, error-prone process into a streamlined, intelligent workflow—right within your QMS software.
If you're aiming for tighter control, better traceability, and true ISO alignment, it’s time to explore COA automation as a strategic lever in your quality transformation journey.

Commercial real estate transactions involve significant investments, complex legal requirements, and extensive documentation. Ensuring compliance with zoning laws, environmental regulations, and property ownership verification is critical to mitigating risks and preventing legal complications. Certificates of Authenticity (COAs) play a crucial role in this process by verifying the authenticity of key documents and facilitating due diligence. In this blog, we explore how COAs enhance compliance, streamline documentation, and reduce transaction delays in commercial real estate.
COAs serve as official documentation that verifies the legitimacy of critical property-related records. Whether confirming zoning compliance, environmental certifications, or ownership history, these certificates provide assurance to buyers, sellers, and financial institutions. By ensuring that all documentation is verified and legally compliant, COAs help prevent fraudulent transactions and costly legal disputes.
Managing COAs manually can be time-consuming and prone to errors. Automation offers a more efficient approach by:
COAs are indispensable in commercial real estate transactions, ensuring compliance with zoning laws, environmental regulations, and ownership verification. By leveraging automation, real estate firms can streamline COA management, minimize risks, and facilitate smoother transactions. Investing in digital COA solutions not only enhances efficiency but also builds trust and credibility in the commercial real estate market.